Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Case report: Multicentric Castleman disease as a manifestation of immune reconstitution inflammatory syndrome in Malawi

Frontiers in Oncology(2022)10.3389/fonc.2022.969135Source: DataRank Database

Case report: Multicentric Castleman disease as a manifestation of immune reconstitution inflammatory syndrome in Malawi is a research paper published in Frontiers in Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.28)OA: goldTopics (31)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Marriam Mponda,Tamiwe Tomoka ORCID,Coxcilly Kampani,Fred Chimzimu,Yuri Fedoriw ORCID

Live enrichment

PubMed:36578926 PMC:PMC9791082 OpenAlex:https://openalex.org/W4312123625

Fogarty International Center

Grant: K01TW011470

National Cancer Institute

Grant: U54CA25464, U54CA190152

FIC NIH HHS

Grant: L30 TW011802

NCI NIH HHS

Grant: D43 CA260641

NCI NIH HHS

Grant: U54 CA254564

NCI NIH HHS

Grant: L30 CA233709

NCI NIH HHS

Grant: U54 CA190152

National Institutes of Health

Grant: 1K01TW011470-01

Safety, efficacy, and cost-effectiveness of rituximab for multicentric Castleman disease in Malawi

National Institutes of Health

Grant: 5U54CA190152-04

Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu

FWCI

0.28

Citation Percentile

0.6%

Citation Trend

2023

2024

goldLicense: cc-by

journalhttps://www.frontiersin.org/articles/10.3389/fonc.2022.969135/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2022.969135/pdf

publisherhttps://www.frontiersin.org/articles/10.3389/fonc.2022.969135/full

journalhttps://doi.org/10.3389/fonc.2022.969135

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36578926

Fields of Study

Viral-associated cancers and disordersAutoimmune and Inflammatory Disorders ResearchInfectious Diseases and Tuberculosis03 medical and health sciences0302 clinical medicine

Keywords

Immune systemImmune reconstitution inflammatory syndromeMedicineDiseaseImmunologyPathologyHuman immunodeficiency virus (HIV)Antiretroviral therapyHIVAfricairisMalawiKshvMulticentric Castleman DiseaseRheumatologyHealth SciencesViral loadPost-Transplant Lymphoproliferative DiseaseRC254-282FOS: Clinical medicineNeoplasms. Tumors. Oncology. Including cancer and carcinogensDiagnosis and Treatment of Primary Central Nervous System LymphomaNeurologyOncologyDiagnosis and Management of IgG4-Related DiseaseViral-Related Cancers in Immunocompromised Patients

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being